Literature DB >> 7432558

Stopped-flow studies on drug-protein binding. 1. Kinetics of warfarin binding to human serum albumin.

N Rietbrock, A Lassmann.   

Abstract

We have studied the binding of warfarin to human serum albumin (HSA) with the stopped-flow method. At 37 degrees C the rate constant for the velocity of dissociation of the stable warfarin-HSA complex is 10 S-1 (t50% = 0.07 s). Concentration and temperature dependent association constants for warfarin binding to HSA have been measured (2.5 x 10(5) M-1 S-1 at 6 degrees C, 9.8 x 10(5) M-1 S-1 at 22 degrees C and 15.3 x 10(5) M-1 S-1 at 37 degrees C). Our experimentally obtained relaxation constants are best explained by the existence of 5 equivalent low affinity binding sites for warfarin on the HSA molecule, each capable of conversion into a high affinity site. The measured energy of activation for this conversion is 57.5 kJ M-1.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7432558     DOI: 10.1007/bf00505744

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

1.  Effect of temperature on binding of warfarin by human serum albumin.

Authors:  Y T Oester; S Keresztes-Nagy; R F Mais; J Becktel; J F Zaroslinski
Journal:  J Pharm Sci       Date:  1976-11       Impact factor: 3.534

2.  A rotating iterative procedure (RIP) for estimating hybrid constants in multi-compartment analysis on desk computers.

Authors:  H M von Hattingberg; D Brockmeier; G Kreuter
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

3.  Kinetics of bilirubin binding to bovine serum albumin and the effects of palmitate.

Authors:  R G Reed
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

4.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

5.  Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.

Authors:  R F Mais; S Keresztes-Nagy; J F Zaroslinski; Y T Oester
Journal:  J Pharm Sci       Date:  1974-09       Impact factor: 3.534

6.  Optical studies of drug-protein complexes. IV. The interaction of warfarin and dicoumarol with human serum albumin.

Authors:  C F Chignell
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

7.  Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.

Authors:  J P Tillement; R Zini; P d' Athis; G Vassent
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

  7 in total
  7 in total

1.  Age-dependence and free fatty acid modulation of binding kinetics at the benzodiazepine binding site of serum albumin in neonates and adults determined using fast reaction methods.

Authors:  G Menke; P Pfister; S Sauerwein; I Rietbrock; B G Woodcock; N Rietbrock
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

2.  Stopped-flow studies on drug-protein binding. Analog-computer analysis of the pH-dependent binding kinetics of warfarin and human serum albumin.

Authors:  A Lassmann; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

3.  Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths.

Authors:  G Menke; W Wörner; W Kratzer; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling.

Authors:  Zenghan Tong; David S Hage
Journal:  J Chromatogr A       Date:  2011-08-17       Impact factor: 4.759

5.  Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns.

Authors:  Zenghan Tong; John E Schiel; Efthimia Papastavros; Corey M Ohnmacht; Quentin R Smith; David S Hage
Journal:  J Chromatogr A       Date:  2010-10-23       Impact factor: 4.759

6.  Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.

Authors:  John E Schiel; Corey M Ohnmacht; David S Hage
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

7.  Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography.

Authors:  Jianzhong Chen; John E Schiel; David S Hage
Journal:  J Sep Sci       Date:  2009-05       Impact factor: 3.645

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.